73475-1221-1 : NDC 2026 Code

73475-1221-1 : Efgartigimod Alfa And Hyaluronidase (human Recombinant) ( Vyvgart Hytrulo )

Additionally :

You can get information about “73475-1221-1” NDC code in 73475-1221-1 in HTML format

HTML | 73475-1221-1 in TXT (Plain Text) format

TXT | 73475-1221-1 in PDF (Portable Document Format)

PDF | 73475-1221-1 in XML format

XML formats.

NDC Code : 73475-1221-1 – JSON Data Format

                
{
  "NDC": {
    "NDCCode": "73475-1221-1",
    "PackageDescription": "1 SYRINGE, GLASS in 1 CARTON (73475-1221-1)  / 5 mL in 1 SYRINGE, GLASS",
    "NDC11Code": "73475-1221-01",
    "ProductNDC": "73475-1221",
    "ProductTypeName": "HUMAN PRESCRIPTION DRUG",
    "ProprietaryName": "Vyvgart Hytrulo",
    "ProprietaryNameSuffix": null,
    "NonProprietaryName": "Efgartigimod Alfa And Hyaluronidase (human Recombinant)",
    "DosageFormName": "INJECTION, SOLUTION",
    "RouteName": "SUBCUTANEOUS",
    "StartMarketingDate": "20250410",
    "EndMarketingDate": null,
    "MarketingCategoryName": "BLA",
    "ApplicationNumber": "BLA761304",
    "LabelerName": "argenx US",
    "SubstanceName": "EFGARTIGIMOD ALFA; HYALURONIDASE (HUMAN RECOMBINANT)",
    "StrengthNumber": "200; 2000",
    "StrengthUnit": "mg/mL; U/mL",
    "Pharm_Classes": "Endoglycosidase [EPC], Glycoside Hydrolases [CS], Neonatal Fc Receptor Blocker [EPC], Neonatal Fc Receptor Blockers [MoA]",
    "DEASchedule": null,
    "Status": "Active",
    "LastUpdate": "2025-12-05",
    "PackageNdcExcludeFlag": "N",
    "ProductNdcExcludeFlag": "N",
    "ListingRecordCertifiedThrough": "20261231",
    "StartMarketingDatePackage": "20250410",
    "EndMarketingDatePackage": null,
    "SamplePackage": "N"
  }
}